The platelet P2Y₁₂ receptor contributes to granule secretion through Ephrin A4 receptor

References

• Kahner BN, Shankar H, Murugappan S, Prasad GL, Kunapuli SP. Nucleotide receptor signaling in platelets. J Thromb Haemost 2006; 4: 2317–2326
   PubMed Web of Science ®Google Scholar
• Gachet C. Regulation of platelet functions by P2 receptor. Annu Rev Pharmacol Toxicol 2006; 46: 277–300
   PubMed Web of Science ®Google Scholar
• Cattaneo M. Disorders of platelet function. Abnormalities of the platelet P2 receptors. Pathophysiol Haemost Thromb 2006; 35: 10–14
   PubMedGoogle Scholar
• Jones CI, Bray S, Garner SF, Stephens J, de Bono B, Angenent WG, Bentley D, Burns P, Coffey A, Deloukas P, et al. A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood 2009; 114: 1405–1416
   PubMed Web of Science ®Google Scholar
• CAPRIE. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329–1339
   PubMed Web of Science ®Google Scholar
• Yan R, Wang Z, Yuan Y, Cheng H, Dai K. Role of cAMP-dependent protein kinase in the regulation of platelet procoagulant activity. Arch Biochem Biophys 2009; 485: 41–48
   PubMed Web of Science ®Google Scholar
• Kullander K, Klein R. Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol 2002; 3: 475–486
   PubMed Web of Science ®Google Scholar
• Wykosky J, Debinski W. The EphA2 receptor and ephrinA1 ligand in solid tumors: Function and therapeutic targeting. Mol Cancer Res 2008; 6: 1795–1806
   PubMed Web of Science ®Google Scholar
• Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008; 133: 38–52
   PubMed Web of Science ®Google Scholar
• Lackmann M, Boyd AW. Eph, a protein family coming of age: More confusion, insight, or complexity?. Sci Signal 2008; 1: re2
   PubMed Web of Science ®Google Scholar
• Abdul-Aziz NM, Turmaine M, Greene ND, Copp AJ. EphrinA-EphA receptor interactions in mouse spinal neurulation: Implications for neural fold fusion. Int J Dev Biol 2009; 53: 559–568
   PubMed Web of Science ®Google Scholar
• Irie N, Takada Y, Watanabe Y, Matsuzaki Y, Naruse C, Asano M, Iwakura Y, Suda T, Matsuo K. Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis. J Biol Chem 2009; 284: 14637–14644
   PubMedGoogle Scholar
• Konstantinova I, Nikolova G, Ohara-Imaizumi M, Meda P, Kucera T, Zarbalis K, Wurst W, Nagamatsu S, Lammert E. EphA-Ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic islets. Cell 2007; 129: 359–370
   PubMed Web of Science ®Google Scholar
• Herbert SP, Huisken J, Kim TN, Feldman ME, Houseman BT, Wang RA, Shokat KM, Stainier DY. Arterial-venous segregation by selective cell sprouting: An alternative mode of blood vessel formation. Science 2009; 326: 294–298
   PubMed Web of Science ®Google Scholar
• Prevost N, Woulfe D, Tanaka T, Brass LF. Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred. Proc Natl Acad Sci USA 2002; 99: 9219–9224
   PubMed Web of Science ®Google Scholar
• Prevost N, Woulfe DS, Jiang H, Stalker TJ, Marchese P, Ruggeri ZM, Brass LF. Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. Proc Natl Acad Sci USA 2005; 102: 9820–9825
   PubMed Web of Science ®Google Scholar
• Prevost N, Woulfe DS, Tognolini M, Tanaka T, Jian W, Fortna RR, Jiang H, Brass LF. Signaling by ephrinB1 and Eph kinases in platelets promotes Rap1 activation, platelet adhesion, and aggregation via effector pathways that do not require phosphorylation of ephrinB1. Blood 2004; 103: 1348–1355
   PubMed Web of Science ®Google Scholar
• Lewandrowski U, Wortelkamp S, Lohrig K, Zahedi RP, Wolters DA, Walter U, Sickmann A. Platelet membrane proteomics: A novel repository for functional research. Blood 2009; 114: e10–e19
   PubMed Web of Science ®Google Scholar
• Dittrich M, Birschmann I, Mietner S, Sickmann A, Walter U, Dandekar T. Platelet protein interactions: Map, signaling components, and phosphorylation groundstate. Arterioscler Thromb Vasc Biol 2008; 28: 1326–1331
   PubMed Web of Science ®Google Scholar
• Tucker KL, Kaiser WJ, Bergeron AL, Hu H, Dong JF, Tan TH, Gibbins JM. Proteomic analysis of resting and thrombin-stimulated platelets reveals the translocation and functional relevance of HIP-55 in platelets. Proteomics 2009; 9: 4340–4354
   PubMed Web of Science ®Google Scholar
• Noberini R, Koolpe M, Peddibhotla S, Dahl R, Su Y, Cosford ND, Roth GP, Pasquale EB. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors. J Biol Chem 2008; 283: 29461–29472
   PubMed Web of Science ®Google Scholar
• Korporaal SJ, van Eck M, Adelmeijer J, Ijsseldijk M, Out R, Lisman T, Lenting PJ, Van Berkel TJ, Akkerman JW. Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A. Arterioscler Thromb Vasc Biol 2007; 27: 2476–2483
   PubMed Web of Science ®Google Scholar
• Hilhorst R, Houkes L, van den Berg A, Ruijtenbeek R. Peptide micro-arrays for detailed, high-throughput substrate identification, kinetic characterisation and inhibition studies on Protein Kinase A. Anal Biochem 2009; 387: 150–161
   PubMed Web of Science ®Google Scholar
• Lemeer S, Jopling C, Naji F, Ruijtenbeek R, Slijper M, Heck AJ, den Hertog J. Protein-tyrosine kinase activity profiling in knock down zebrafish embryos. PLoS ONE 2007; 2: e581
   Web of Science ®Google Scholar
• de Haas CJ, Weeterings C, Vughs MM, de Groot PG, Van Strijp JA, Lisman T. Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibalpha and alphabeta. J Thromb Haemost 2009; 7: 1867–1874
   PubMed Web of Science ®Google Scholar
• Jakobs KH, Wieland T. Evidence for receptor-regulated phosphotransfer reactions involved in activation of the adenylate cyclase inhibitory G protein in human platelet membranes. Eur J Biochem 1989; 183: 115–121
   PubMedGoogle Scholar
• Lanza F, Beretz A, Stierlé A, Hanau D, Kubina M, Cazenave JP. Epinephrine potentiates human platelet activation but is not an aggregating agent. Am J Physiol 1988; 255: H1276–1288
   Google Scholar
• Remijn JA, Wu YP, Jeninga EH, Ijsseldijk MJ, van Willigen G, de Groot PG, Sixma JJ, Nurden AT, Nurden P. Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood. Arterioscler Thromb Vasc Biol 2002; 22: 686–691
   PubMed Web of Science ®Google Scholar
• Qin H, Shi J, Noberini R, Pasquale EB, Song J. Crystal structure and NMR binding reveal that two small molecule antagonists target the high affinity ephrin-binding channel of the EphA4 receptor. J Biol Chem 2008; 283: 9473–9484
   Web of Science ®Google Scholar
• White JG, Witkop CJ. Effects of normal and aspirin platelets on defective secondary aggregation in the Hermansky-Pudlak syndrome. A test for storage pool deficient platelets. Am J Pathol 1972; 68: 57–66
   PubMed Web of Science ®Google Scholar
• Foster CJ, Prosser DM, Agans JM, Zhai Y, Smith MD, Lachowicz JE, Zhang FL, Gustafson E, Monsma FJ, Jr, Wiekowski MT, et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 2001; 107: 1591–1598
   PubMed Web of Science ®Google Scholar
• Tanaka M, Kamata R, Yanagihara K, Sakai R. Suppression of gastric cancer dissemination by ephrin-B1-derived peptide. Cancer Sci 2010; 101: 87–93
   Google Scholar